Clinical Trial Update: Cancer Preventive Vaccine Nous-209 for Lynch Syndrome Patients [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on the cancer preventive vaccine Nous-209 for Lynch syndrome patients, with Phase 1 and Phase 2 trials currently active but not recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Lynch Syndrome

Drugs mentioned

• Nous-209

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Colorectal Carcinoma, Lynch Syndrome | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING